General Information of Drug Transporter (DT)
DT ID DTD0055 Transporter Info
Gene Name ABCB9
Transporter Name TAP-like protein
Gene ID
23457
UniProt ID
Q9NP78
Post-Translational Modification of This DT
Overview of ABCB9 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Oxidation X-Phosphorylation X-S-nitrosylation X-S-sulfenylation X-Ubiquitination X: Amino Acid

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCB9 [1]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

548

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at ABCB9 Cystine 548 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCB9 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

105

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCB9 Serine 105 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCB9 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

240

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCB9 Serine 240 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCB9 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

325

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCB9 Serine 325 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCB9 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

528

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCB9 Serine 528 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence ABCB9 [2] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

530

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCB9 Serine 530 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCB9 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

227

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCB9 Threonine 227 has the potential to affect its expression or activity.

S-nitrosylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCB9 [6]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

548

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation (-SNO) at ABCB9 Cystine 548 has the potential to affect its expression or activity.

S-sulfenylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCB9 [7]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

548

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-sulfenylation (-SOH) at ABCB9 Cystine 548 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCB9 [8]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

376

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at ABCB9 Lysine 376 has the potential to affect its expression or activity.
References
1 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
2 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
4 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
5 Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates. Cell Metab. 2015 Nov 3;22(5):922-35.
6 MDD-SOH: exploiting maximal dependence decomposition to identify S-sulfenylation sites with substrate motifs. Bioinformatics. 2016 Jan 15;32(2):165-72.
7 Site-specific mapping and quantification of protein S-sulphenylation in cells. Nat Commun. 2014 Sep 1;5:4776.
8 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.